Asceneuron

is a Switzerland-based biotechnology company that researches and develops novel therapeutics for the treatment of neurodegenerative diseases...
Read more
Asceneuron CEO: Barbara Angehrn Pavik

CEO

Barbara Angehrn Pavik

CEO Approval Rating

85/100

Est. Annual Revenue
$5.0-25M
Agree?
Est. Employees
25-100
Agree?
Funding
$132.8M

Asceneuron Competitors

1AC Immune
2GeNeuro
3Alzinova
4Denali
5Spark Therapeutics
6Alector
7Yumanity
8AXON Neuroscience
9Homology
10Genespire

Trending Companies